Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

17.36 -1.04 (-5.63%)
Streaming Delayed Price Updated: 2:55 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 321,087
Open 17.33
Bid (Size) 17.33 (4)
Ask (Size) 17.38 (3)
Prev. Close 18.39
Today's Range 16.72 - 17.60
52wk Range 7.420 - 34.84
Shares Outstanding 52,627,165
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling more than 250 points on Monday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
-19.4%
-19.4%
1 Month
-17.9%
-17.9%
3 Month
-19.4%
-19.4%
6 Month
-44.3%
-44.3%
1 Year
+74.4%
+74.4%

More News

Read More
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire
Where CareDx Stands With Analysts
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Breaking Down CareDx: 3 Analysts Share Their Views
Via Benzinga
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta
Via Benzinga
CareDx Launches Two Expanded Indications for AlloSure Testing Services
From CareDx, Inc.
Via Business Wire
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire
CareDx Announces Fourth Quarter and Full Year 2024 Financial Results
From CareDx, Inc.
Via Business Wire
Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict
From CareDx, Inc.
Via Business Wire
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
From Johnson Fistel, LLP
Via Business Wire
CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies
From CareDx, Inc.
Via Business Wire
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results
From CareDx, Inc.
Via Business Wire
Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results
From CareDx, Inc.
Via Business Wire
CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From CareDx, Inc.
Via Business Wire
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) and CareDx Collaborate to Enhance TCB008 Cell Therapy Development for AML
Via Investor Brand Network
CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy
From CareDx, Inc.
Via Business Wire
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
From CareDx, Inc.
Via Business Wire

Frequently Asked Questions

Is CareDx, Inc. - Common Stock publicly traded?
Yes, CareDx, Inc. - Common Stock is publicly traded.
What exchange does CareDx, Inc. - Common Stock trade on?
CareDx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CareDx, Inc. - Common Stock?
The ticker symbol for CareDx, Inc. - Common Stock is CDNA on the Nasdaq Stock Market
What is the current price of CareDx, Inc. - Common Stock?
The current price of CareDx, Inc. - Common Stock is 17.36
When was CareDx, Inc. - Common Stock last traded?
The last trade of CareDx, Inc. - Common Stock was at 04/03/25 02:55 PM ET
What is the market capitalization of CareDx, Inc. - Common Stock?
The market capitalization of CareDx, Inc. - Common Stock is 913.34M
How many shares of CareDx, Inc. - Common Stock are outstanding?
CareDx, Inc. - Common Stock has 913M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.